The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...